Rep. Greg Stanton (D-AZ) Sells Shares of Trulieve Cannabis Corp.

U.S. Rep. Greg Stanton sold Trulieve Cannabis shares valued between $100,001 and $250,000.

Greg Stanton

Financial Disclosure Report

Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515

Filer Information

Name:
Rep. Greg Stanton (D-AZ)
Status:
Member — House
State/District:
AZ-4
Party:
democrat

Filing Information

Filing Type:
Periodic Transaction Report
Filing Year:
2026
Filing Date:
Jun 26, 2026

Schedule B: Transactions

AssetTransactionDateAmount
Trulieve Cannabis Corp. ($TCNNF) Sell May 28, 2026 $100,001 - $250,000

Key Points

  • On May 28, 2026, Rep. Greg Stanton sold Trulieve Cannabis shares valued between $100,001 and $250,000.
  • Trulieve Cannabis trades on the OTC Markets, with shares priced at $9.24 as of Wednesday.
  • The company reported revenue of $1.17 billion and a net margin of -6.93% for the recent period.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

U.S. Representative Greg Stanton, a Democrat from Arizona's 4th district, sold shares of Trulieve Cannabis Corp. on May 28, 2026. The sale was valued between $100,001 and $250,000, according to his disclosure filed under the STOCK Act. This transaction was reported on June 26, 2026.

Congressional trading track record

Greg Stanton vs. the S&P 500

YTD return +6.97% hypothetical
All-time return +69.50% S&P 500 +78.67%
vs. S&P 500 -9.17% behind the index

Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.

Trulieve Cannabis Corp. Stock Up 10.6%

Shares of Trulieve Cannabis Corp. (OTC Markets: TCNNF) traded near $9.24 on Wednesday. The company has a market cap of approximately $1.89 billion. It is not profitable, as indicated by its negative earnings per share (EPS) of -$0.38. However, it has a forward P/E ratio of 41.04. Trulieve's stock has a 52-week low of $7.92 and a high of $13.28. The company's financial health shows a current ratio of 5.26 and a quick ratio of 3.01, with a debt-to-equity ratio of 54.80.

Year to date

$TCNNF stock price

Daily closing prices, year to date. Not investment advice.

Recent Earnings

Trulieve Cannabis reported revenue of about $1.17 billion, though it faced a revenue decline of 3.7%. The company experienced a net margin of -6.93% and a return on equity of -6.85%. Investors are looking ahead to the next earnings report, expected on August 6, 2026.

About Trulieve Cannabis Corp.

Trulieve Cannabis Corp. is a major player in the U.S. cannabis market, headquartered in Tallahassee, Florida. The company focuses on cultivating, processing, and selling cannabis products. Trulieve operates dispensaries across several states, including Florida, Arizona, and Pennsylvania. It offers a variety of products such as flowers, edibles, and vapes under various brand names. Led by CEO Kimberly Rivers, Trulieve employs around 5,000 people and continues to expand its footprint in the cannabis industry.

Bottom Line

Rep. Greg Stanton's recent sale of Trulieve Cannabis shares is a routine disclosure under the STOCK Act, reflecting transactions after they occur. Trulieve remains a significant player in the cannabis industry, with investors keeping an eye on its financial performance and future growth prospects. As always, these filings provide a snapshot of past activity and should not be considered current investment advice.

Get Trulieve Cannabis Corp. alerts

New 13F filings, insider trades, and analyst moves on $TCNNF, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.